Literature DB >> 15284109

Mutations of the SBDS gene are present in most patients with Shwachman-Diamond syndrome.

Jill R Woloszynek1, Robert J Rothbaum, Amy S Rawls, Patrick J Minx, Richard K Wilson, Philip J Mason, Monica Bessler, Daniel C Link.   

Abstract

Shwachman-Diamond Syndrome (SDS) is a rare multisystem disorder characterized by exocrine pancreatic insufficiency, bone marrow dysfunction, and metaphyseal chondrodysplasia. Recent studies show that mutations of SBDS, a gene of unknown function, are present in the majority of patients with SDS. In the present study, we show that most, but not all, patients classified based on rigorous clinical criteria as having SDS had compound heterozygous mutations of SBDS. Full-length SBDS protein was not detected in leukocytes of SDS patients with the most common SBDS mutations, consistent with a loss-of-function mechanism. In contrast, SBDS protein was expressed at normal levels in SDS patients without SBDS mutations. These data confirm the absence of SBDS mutations in this subgroup of patients and suggest that SDS is a genetically heterogeneous disorder. The presence (or absence) of SBDS mutations may define subgroups of patients with SDS who share distinct clinical features or natural history.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15284109     DOI: 10.1182/blood-2004-04-1516

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  36 in total

Review 1.  Neonatal manifestations of inherited bone marrow failure syndromes.

Authors:  Payal P Khincha; Sharon A Savage
Journal:  Semin Fetal Neonatal Med       Date:  2015-12-24       Impact factor: 3.926

2.  Ubiquitin-proteasome-rich cytoplasmic structures in neutrophils of patients with Shwachman-Diamond syndrome.

Authors:  Vittorio Necchi; Antonella Minelli; Patrizia Sommi; Agostina Vitali; Roberta Caruso; Daniela Longoni; Maria Rita Frau; Cristina Nasi; Fabiola De Gregorio; Marco Zecca; Vittorio Ricci; Cesare Danesino; Enrico Solcia
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941

3.  Anticipating the 1,000 dollar genome.

Authors:  Elaine R Mardis
Journal:  Genome Biol       Date:  2006       Impact factor: 13.583

4.  Lentiviral-mediated RNAi inhibition of Sbds in murine hematopoietic progenitors impairs their hematopoietic potential.

Authors:  Amy S Rawls; Alyssa D Gregory; Jill R Woloszynek; Fulu Liu; Daniel C Link
Journal:  Blood       Date:  2007-07-17       Impact factor: 22.113

5.  Shwachman-Diamond syndrome in a child presenting with cystic fibrosis-type symptoms and a false-positive sweat test.

Authors:  S M N Brown; R Buchdahl
Journal:  J R Soc Med       Date:  2008-07       Impact factor: 5.344

6.  Mutations of the Shwachman-Bodian-Diamond syndrome gene in patients presenting with refractory cytopenia--do we have to screen?

Authors:  Axel Karow; Christian Flotho; Michaela Schneider; Manfred Fliegauf; Charlotte M Niemeyer
Journal:  Haematologica       Date:  2009-11-30       Impact factor: 9.941

7.  Mislocalization or low expression of mutated Shwachman-Bodian-Diamond syndrome protein.

Authors:  Masafumi Yamaguchi; Kingo Fujimura; Hirokazu Kanegane; Hanae Toga-Yamaguchi; Rajesh Chopra; Naoki Okamura
Journal:  Int J Hematol       Date:  2011-06-10       Impact factor: 2.490

Review 8.  Genetic heterogeneity in severe congenital neutropenia: how many aberrant pathways can kill a neutrophil?

Authors:  Alejandro A Schäffer; Christoph Klein
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-12

9.  The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA.

Authors:  Karthik A Ganapathi; Karyn M Austin; Chung-Sheng Lee; Anusha Dias; Maggie M Malsch; Robin Reed; Akiko Shimamura
Journal:  Blood       Date:  2007-05-02       Impact factor: 22.113

10.  Mutations in the SBDS gene in acquired aplastic anemia.

Authors:  Rodrigo T Calado; Solomon A Graf; Keisha L Wilkerson; Sachiko Kajigaya; Philip J Ancliff; Yigal Dror; Stephen J Chanock; Peter M Lansdorp; Neal S Young
Journal:  Blood       Date:  2007-05-03       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.